Myeong Ok Kim Selected Research

JNK Mitogen-Activated Protein Kinases

6/2021	17-β Estradiol Rescued Immature Rat Brain against Glutamate-Induced Oxidative Stress and Neurodegeneration via Regulating Nrf2/HO-1 and MAP-Kinase Signaling Pathway.
1/2020	Inhibition of JNK Alleviates Chronic Hypoperfusion-Related Ischemia Induces Oxidative Stress and Brain Degeneration via Nrf2/HO-1 and NF-κB Signaling.
1/2020	Oral Administration of Alpha Linoleic Acid Rescues Aβ-Induced Glia-Mediated Neuroinflammation and Cognitive Dysfunction in C57BL/6N Mice.
5/2019	MST1 Regulates Neuronal Cell Death via JNK/Casp3 Signaling Pathway in HFD Mouse Brain and HT22 Cells.
1/2019	Melatonin Rescue Oxidative Stress-Mediated Neuroinflammation/ Neurodegeneration and Memory Impairment in Scopolamine-Induced Amnesia Mice Model.
4/2018	17β-Estradiol via SIRT1/Acetyl-p53/NF-kB Signaling Pathway Rescued Postnatal Rat Brain Against Acute Ethanol Intoxication.
1/2018	Inhibition of c-Jun N-Terminal Kinase Protects Against Brain Damage and Improves Learning and Memory After Traumatic Brain Injury in Adult Mice.
3/2016	Protective Effect of Lupeol Against Lipopolysaccharide-Induced Neuroinflammation via the p38/c-Jun N-Terminal Kinase Pathway in the Adult Mouse Brain.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Myeong Ok Kim Research Topics

Disease

51	Neuroinflammatory Diseases 11/2022 - 01/2015
36	Alzheimer Disease (Alzheimer's Disease) 11/2022 - 07/2011
36	Neurodegenerative Diseases (Neurodegenerative Disease) 05/2022 - 01/2007
16	Nervous System Diseases (Neurological Disorders) 01/2021 - 05/2012
12	Cognitive Dysfunction 01/2022 - 08/2015
12	Gliosis 10/2021 - 01/2015
9	Inflammation (Inflammations) 05/2022 - 01/2019
9	Neoplasms (Cancer) 02/2022 - 01/2008
7	Parkinson Disease (Parkinson's Disease) 09/2020 - 07/2014
5	Brain Injuries (Brain Injury) 10/2021 - 01/2019
5	Memory Disorders (Memory Loss) 01/2021 - 08/2015
5	Insulin Resistance 01/2021 - 01/2017
4	Traumatic Brain Injuries (Traumatic Brain Injury) 05/2022 - 01/2018
4	Obesity 01/2021 - 10/2013
4	Alcoholism (Alcohol Abuse) 01/2015 - 09/2011
3	Mitochondrial Diseases (Mitochondrial Disease) 05/2022 - 03/2019
3	B-Cell Lymphoma (Lymphoma, B Cell) 01/2022 - 03/2019
3	Necrosis 09/2021 - 09/2017
3	Body Weight (Weight, Body) 01/2020 - 10/2013
3	Disease Progression 03/2019 - 01/2017
3	Neuroblastoma 01/2017 - 10/2015
3	Prostatic Neoplasms (Prostate Cancer) 04/2012 - 09/2008
3	Fetal Alcohol Spectrum Disorders 09/2011 - 09/2008
2	COVID-19 11/2022 - 02/2022
2	Wounds and Injuries (Trauma) 10/2021 - 01/2020
2	Carcinoma (Carcinomatosis) 01/2019 - 10/2006
2	Stroke (Strokes) 01/2018 - 10/2016

Drug/Important Bio-Agent (IBA)

25	Neuroprotective AgentsIBA 09/2021 - 01/2011
24	AntioxidantsIBA 11/2022 - 07/2014
18	Amyloid beta-PeptidesIBA 11/2022 - 01/2015
17	Reactive Oxygen Species (Oxygen Radicals)IBA 04/2021 - 01/2015
13	Proteins (Proteins, Gene)FDA Link 05/2022 - 09/2008
13	Anthocyanins (Anthocyanin)IBA 01/2021 - 10/2013
10	LipopolysaccharidesIBA 12/2020 - 03/2016
10	Ethanol (Ethyl Alcohol)IBA 05/2019 - 09/2008
9	FlavonoidsIBA 09/2021 - 11/2016
8	JNK Mitogen-Activated Protein KinasesIBA 06/2021 - 03/2016
8	MelatoninIBA 01/2021 - 01/2015
7	NF-kappa B (NF-kB)IBA 09/2021 - 01/2016
6	CytokinesIBA 11/2022 - 01/2020
6	Pharmaceutical PreparationsIBA 07/2021 - 04/2012
6	Galactose (Galactopyranose)FDA LinkGeneric 01/2021 - 01/2015
5	Sirtuin 1IBA 01/2022 - 01/2017
5	Phosphotransferases (Kinase)IBA 10/2021 - 01/2019
5	Caspase 3 (Caspase-3)IBA 04/2021 - 01/2019
5	AdiponectinIBA 01/2021 - 01/2017
5	Glucose (Dextrose)FDA LinkGeneric 01/2021 - 01/2017
4	Amyloid (Amyloid Fibrils)IBA 01/2022 - 07/2011
4	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 10/2021 - 01/2016
4	Glutamic Acid (Glutamate)FDA Link 06/2021 - 05/2015
4	Niacinamide (Nicotinamide)FDA LinkGeneric 04/2021 - 01/2011
4	Caffeine (No Doz)FDA LinkGeneric 09/2020 - 11/2015
3	lupeolIBA 05/2022 - 03/2016
3	CurcuminIBA 02/2022 - 01/2019
3	Cytochromes c (Cytochrome c)IBA 01/2022 - 01/2019
3	Toll-Like Receptor 4IBA 10/2021 - 04/2016
3	Insulin (Novolin)FDA Link 01/2021 - 06/2017
3	gintoninIBA 01/2021 - 01/2019
3	fisetinIBA 01/2021 - 01/2017
3	SynucleinsIBA 09/2020 - 01/2017
3	hesperetinIBA 07/2020 - 03/2019
3	Adiponectin ReceptorsIBA 01/2020 - 01/2017
2	Adenosine Triphosphate (ATP)IBA 01/2022 - 01/2018
2	Malondialdehyde (Propanedial)IBA 04/2021 - 01/2019
2	Glycogen Synthase Kinase 3 betaIBA 01/2021 - 01/2015
2	CadmiumIBA 01/2021 - 05/2019
2	Glycine (Aminoacetic Acid)FDA LinkGeneric 10/2020 - 01/2016
2	pyrazolanthroneIBA 01/2020 - 01/2018
2	Free RadicalsIBA 05/2019 - 07/2014
2	Heme Oxygenase-1IBA 05/2019 - 01/2019
2	tau Proteins (tau Protein)IBA 03/2019 - 01/2017
2	Biomarkers (Surrogate Marker)IBA 01/2019 - 04/2012
2	CalciumIBA 01/2018 - 09/2017
2	GoldIBA 11/2017 - 10/2017
2	Peptides (Polypeptides)IBA 09/2017 - 07/2011
2	Hormones (Hormone)IBA 01/2017 - 09/2008
2	Ascorbic Acid (Vitamin C)FDA LinkGeneric 03/2015 - 08/2008
2	gamma-Aminobutyric Acid (GABA)IBA 03/2015 - 09/2011
2	Dopamine (Intropin)FDA LinkGeneric 07/2014 - 04/2009
2	Pyruvic Acid (Pyruvate)IBA 12/2013 - 12/2011
1	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 01/2022
1	2- (7- (3,4- dimethoxyphenyl)imidazo(1,2- c)pyrimidin- 5- ylamino)nicotinamideIBA 01/2022
1	Syk KinaseIBA 01/2022
1	Bcl-2-Like Protein 11IBA 01/2022
1	Insulin-Like Growth Factor I (IGF-1)IBA 10/2021
1	MitogensIBA 10/2021
1	TriterpenesIBA 10/2021
1	cycloastragenolIBA 10/2021
1	SaponinsIBA 10/2021
1	kojic acidIBA 10/2021
1	InterleukinsIBA 10/2021
1	LuteolinIBA 09/2021
1	Lysine (L-Lysine)FDA Link 07/2021
1	Polycomb Repressive Complex 2IBA 07/2021
1	Histones (Histone)IBA 07/2021
1	Enhancer of Zeste Homolog 2 ProteinIBA 07/2021
1	Dopamine D2 Receptors (Dopamine D2 Receptor)IBA 01/2021

Therapy/Procedure

8	Therapeutics 02/2022 - 04/2012
3	Oral Administration 01/2021 - 01/2020
3	Intraperitoneal Injections 01/2019 - 03/2015